Thank you so much, and thank you to the three presenters for the excellent presentations.
Ms. MacNaughton, I'm going to use you as an example to anyone in my riding who feels that they can't get anything done at the federal level. I will be using your name shamelessly, and I hope you don't mind.
Most of my questions are going to be addressed to Mr. Casey. I think most of my colleagues don't know, but I actually worked in biotech for a number of years when I came out of MBA school. I worked for a tiny company named GlycoDesign. I helped it go public. It ended up being sold to Inflazyme. Therefore, I'm very familiar with the issues within the industry, first-hand.
You were right in terms of indicating that we have tons of amazing ideas. We have enough money for the start-ups. Many of our ideas are actually sold to larger companies.
One of the key issues that existed then and I still think exists right now is building that capacity to actually help grow a company to the next level. One part is the investment, but the other part, in addition to having the talent—and I do think we do attract our fair share of talent and we could do more—is building that capacity to be able to run that larger organization.
What can we do to help build that capacity?